14-15 November 2018
|European Case Law Identifier:||ECLI:EP:BA:2007:T016607.20070911|
|Date of decision:||11 September 2007|
|Case number:||T 0166/07|
|IPC class:||C12N 15/51|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||HCV Genomic sequences for diagnostics and therapeutics|
|Applicant name:||Novartis Vaccines and Diagnostics, Inc.|
|Relevant legal provisions:||
|Keywords:||Missing statement of grounds|
Summary of Facts and Submissions
I. The proprietor (appellant) filed on 26 January 2007 a notice of appeal against the decision of the opposition division dated 30 November 2006 whereby the European Patent No. 0 585 398 entitled "HCV Genomic sequences for diagnostics and therapeutics" was revoked. The appeal fee was paid on the same day. No statement setting out the grounds of appeal was filed.
II. By a communication dated 22 May 2007 sent by registered letter with advice of delivery, the Registrar of the Board of Appeal informed the appellant that no written statement of grounds of appeal had been filed and that therefore the appeal had to be rejected as inadmissible. The appellant was invited to file observations within two months and attention was drawn to the possibility of filing a request for re-establishment of rights under Article 122 EPC. The appellant did not reply to said communication and no request for re-establishment of rights was filed. Upon enquiry by the Registrar, the representative of the appellant confirmed that no such request had been filed.
Reasons for the Decision
As no written statement setting out the grounds of appeal has been filed and as the notice of appeal does not contain any statement that could be regarded as a statement of grounds of appeal pursuant to Article 108 EPC, the appeal has to be rejected as inadmissible (Article 108 EPC in conjunction with Rule 65(1) EPC).
For these reasons it is decided that:
The appeal is rejected as inadmissible.